NKX019, Intravenous Allogeneic Chimeric Antigen Receptor Natural Killer Cells (CAR NK), in Adults With B-cell Cancers
Nkarta, Inc.
Nkarta, Inc.
Merck Sharp & Dohme LLC
Atara Biotherapeutics
Novartis
Shenzhen BinDeBio Ltd.
Regeneron Pharmaceuticals
Regeneron Pharmaceuticals
Morphotek
Cellerant Therapeutics
INSYS Therapeutics Inc
Novartis
Enzon Pharmaceuticals, Inc.
Daiichi Sankyo
MedImmune LLC